Core A: Experimental Animal Core In exploring this viral model for tumor pathogenesis in the brain, experiments involving animal models are an essential component in all three projects. Thoward this end, the goal of the Experimental Animal Core of this program is to support Projects 1 - 3. In this core, we will focus on the following five goals: (i) Generation and maintenance of JCV T-antigen transgenic mice which spontaneously develop cerebellar medulloblastomas. The mice will be utilized to provide tumor tissue for analysis and for therapeutic treatment as outlined in the individual projects. (ii) Generation and analysis of new lines of transgenic and knockout mice. Inducible JCV T-antigen transgenic will be generated, as well as mice with mutant p53 or beta-catenin. JCV T-antigen transgenic mice will be crossed with mice lacking tumor suppressors such as p53 and Rb family members. (iii) Inoculation of established cell lines along the flanks of Nude mice or syngeneic mice for in vivo evaluation of therapeutic strategies as outlined in Projects 1-3. (iv) Transplantation of established cell lines within the brain parenchyma of Nude or syngeneic mice for in vivo evaluation of therapeutic strategies as outlined in Projects 1-3. (v) Inoculation of either tumor tissue or cell lines along the flanks of Nude mice to evaluate tumorigenecity. Tumor tissue will be excised and passed to Core B for analysis and establishment of cell lines for distribution to Projects 1-3.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
2P01NS036466-07A2
Application #
6825075
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
2003-09-30
Project End
2008-05-31
Budget Start
2003-09-30
Budget End
2004-05-31
Support Year
7
Fiscal Year
2003
Total Cost
$259,805
Indirect Cost
Name
Temple University
Department
Type
DUNS #
057123192
City
Philadelphia
State
PA
Country
United States
Zip Code
19122
Johnson, Edward M; Daniel, Dianne C; Gordon, Jennifer (2013) The pur protein family: genetic and structural features in development and disease. J Cell Physiol 228:930-7
Riolfi, Mirko; Ferla, Rita; Del Valle, Luis et al. (2010) Leptin and its receptor are overexpressed in brain tumors and correlate with the degree of malignancy. Brain Pathol 20:481-9
Urbanska, Katarzyna; Pannizzo, Paola; Lassak, Adam et al. (2009) Estrogen receptor beta-mediated nuclear interaction between IRS-1 and Rad51 inhibits homologous recombination directed DNA repair in medulloblastoma. J Cell Physiol 219:392-401
Gualco, Elisa; Wang, Jin Ying; Del Valle, Luis et al. (2009) IGF-IR in neuroprotection and brain tumors. Front Biosci (Landmark Ed) 14:352-75
Rossi, Alessandra; Russo, Giuseppe; Puca, Andrew et al. (2009) The antiretroviral nucleoside analogue Abacavir reduces cell growth and promotes differentiation of human medulloblastoma cells. Int J Cancer 125:235-43
Perez-Liz, Georgina; Del Valle, Luis; Gentilella, Antonio et al. (2008) Detection of JC virus DNA fragments but not proteins in normal brain tissue. Ann Neurol 64:379-87
Fiorilli, Paul; Partridge, Darren; Staniszewska, Izabela et al. (2008) Integrins mediate adhesion of medulloblastoma cells to tenascin and activate pathways associated with survival and proliferation. Lab Invest 88:1143-56
Urbanska, Katarzyna; Pannizzo, Paola; Grabacka, Maja et al. (2008) Activation of PPARalpha inhibits IGF-I-mediated growth and survival responses in medulloblastoma cell lines. Int J Cancer 123:1015-24
Brown, Meghan C; Staniszewska, Izabela; Del Valle, Luis et al. (2008) Angiostatic activity of obtustatin as alpha1beta1 integrin inhibitor in experimental melanoma growth. Int J Cancer 123:2195-203
Brown, Meghan C; Staniszewska, Izabela; Lazarovici, Philip et al. (2008) Regulatory effect of nerve growth factor in alpha9beta1 integrin-dependent progression of glioblastoma. Neuro Oncol 10:968-80

Showing the most recent 10 out of 77 publications